RPH

Florida Cancer Specialists & Research Institute Shares Pharmacy Expertise To Advance Medically Integrated Oncology Care

Retrieved on: 
Wednesday, April 3, 2024

FORT MYERS, Fla., April 3, 2024 /PRNewswire/ -- Florida Cancer Specialists & Research Institute, LLC (FCS) leaders and pharmacy experts will share insights and best practices in specialty pharmacy operations and dispensing that are contributing to positive patient outcomes at the NCODA 2024 Spring Forum in Dallas. The focus of the multi-day gathering, "Driving Optimal Strategies for Patient Care in Medically Integrated Oncology," is on the vital role of pharmacy involvement throughout the entire cancer care continuum.

Key Points: 
  • The focus of the multi-day gathering, "Driving Optimal Strategies for Patient Care in Medically Integrated Oncology," is on the vital role of pharmacy involvement throughout the entire cancer care continuum.
  • "Our Rx To Go team members continue to set the standard of excellence for medically-integrated oncology pharmacy and support services," said FCS President & Managing Physician Lucio Gordan, MD .
  • "They are well-equipped to contribute top-tier knowledge to help steer the future of oncology care."
  • NCODA is a globally recognized not-for-profit organization dedicated to building a patient-centered, medically integrated community of health care providers whose focus is to innovate the continuity of cancer care so that every patient receives the maximum benefit from their cancer treatment.

AvevoRx Announces National Director of Pharmacy Operations Named to Triad Business Journal's "40 Leaders Under 40"

Retrieved on: 
Thursday, February 22, 2024

GREENSBORO, N.C., Feb. 22, 2024 /PRNewswire-PRWeb/ -- AvevoRx, an independent provider of specialty infusion pharmacy services, is proud to announce its National Director of Pharmacy Operations, Justin R. Dent, PharmD, has been named to the Triad Business Journal's prestigious "40 Leaders Under 40" list. The 2024 list spotlights extraordinary young leaders with significant career achievements who work and are civically engaged in the Triad community of North Carolina.

Key Points: 
  • The 2024 list spotlights extraordinary young leaders with significant career achievements who work and are civically engaged in the Triad community of North Carolina.
  • As its National Director of Pharmacy Operations, Dent ensures the smooth and efficient day-to-day operations of AvevoRx's pharmacy services at scale.
  • Dent's most significant achievements include helping to expand the company's national footprint and experience with pharmacy law and accreditation compliance.
  • "Our founders established a solid base, and we're constantly enhancing our operations to provide specialty pharmacy care to as many patients as possible.

LiveWorld Expands Board of Directors with Two Esteemed Pharma Executives

Retrieved on: 
Wednesday, January 17, 2024

LiveWorld, Inc. (OTC Markets: LVWD) today announced the appointment of two distinguished pharmaceutical industry leaders, Jennifer Sherak and Helen S. Chang, RPH, to its Board of Directors.

Key Points: 
  • LiveWorld, Inc. (OTC Markets: LVWD) today announced the appointment of two distinguished pharmaceutical industry leaders, Jennifer Sherak and Helen S. Chang, RPH, to its Board of Directors.
  • Both Jennifer and Helen officially joined the board on January 1, 2024, bringing their wealth of experience and expertise to further guide LiveWorld's growth in the pharmaceutical sector.
  • Helen S. Chang, RPh, most recently Vice President, Marketing at Mesoblast Limited, brings a wealth of knowledge in marketing and pharmaceutical/biotech industry to the LiveWorld Board of Directors.
  • "We are delighted to welcome Jennifer and Helen to the LiveWorld Board of Directors,” said Peter Friedman, Chairman & CEO, LiveWorld, “They are both proven executive leaders in the healthcare and life science industries with business development and marketing expertise.

Florida Cancer Specialists & Research Institute Best Practices Program Improves Treatment Response and Survival for Patients with Multiple Myeloma

Retrieved on: 
Thursday, January 25, 2024

FORT MYERS, Fla., Jan. 25, 2024 /PRNewswire/ -- A best practices program developed at Florida Cancer Specialists & Research Institute (FCS) has been shown to improve outcomes for adult patients prescribed selinexor for the treatment of relapsed/refractory multiple myeloma (RRMM).

Key Points: 
  • A real-world study by FCS authors details a program to improve patient outcomes for multiple myeloma.
  • Results obtained from a one-year retrospective observational study using data collected by FCS' Real-World Evidence team were recently published in Current Oncology.
  • He added, "Our findings, as detailed in this article, support the hypothesis that a best practices program designed around specific anticancer drugs can optimize prescribing practices, leading to better disease control and improvements in a patient's cancer care journey."
  • The FCS Real-World Evidence team works with internal and external partners providing insights to improve treatment decisions and clinical outcomes based on evidence generated using real-world data.

EASTERSEALS NATIONAL BOARD OF DIRECTORS WELCOMES NEW CHAIR, ELECTS NEW MEMBERS AND OFFICERS AT ANNUAL MEETING

Retrieved on: 
Tuesday, October 31, 2023

Winter, a resident of Houston, accumulated more than 32 years in the energy sector with Shell before retiring from the company in December of 2018.

Key Points: 
  • Winter, a resident of Houston, accumulated more than 32 years in the energy sector with Shell before retiring from the company in December of 2018.
  • A community leader for decades, Winter is a founding board member of the Gateway Academy, a Houston-based high school for children with learning disabilities established in 2005.
  • Gateway Academy has expanded its focus to include a post-high school transition program, Advance Houston, for which Winter is Board Chair.
  • "Easterseals is honored to have the commitment of these exceptional corporate and nonprofit leaders on our National Board of Directors," said Easterseals President and CEO Kendra E. Davenport.

NASP Releases Agenda for its 2023 Annual Meeting & Expo

Retrieved on: 
Wednesday, June 21, 2023

Washington, D.C., June 21, 2023 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP), a nonprofit organization representing all specialty pharmacy industry stakeholders, is pleased to announce the full agenda for the NASP 2023 Annual Meeting & Expo.

Key Points: 
  • Washington, D.C., June 21, 2023 (GLOBE NEWSWIRE) -- The National Association of Specialty Pharmacy (NASP), a nonprofit organization representing all specialty pharmacy industry stakeholders, is pleased to announce the full agenda for the NASP 2023 Annual Meeting & Expo.
  • With the growth of the association membership combined with the momentum in the specialty pharmacy industry overall, NASP’s leadership believes this year’ s Annual Meeting & Expo will draw an even bigger crowd.
  • Simply put – it will be our biggest and best meeting to date,” said Sheila M. Arquette, RPH, President & CEO, NASP.
  • For registration and additional information, please visit the NASP 2023 Annual Meeting & Expo website .

Navitus Health Solutions Announces Changes to Board of Directors

Retrieved on: 
Tuesday, January 17, 2023

Navitus Health Solutions, LLC today announced two updates to its Board of Directors.

Key Points: 
  • Navitus Health Solutions, LLC today announced two updates to its Board of Directors.
  • Board Member Richard Stephens, Rph has been named to the role of Vice Chair of Navitus.
  • “We’re thrilled to congratulate Richard on his new role and to welcome Brad to the Board of Directors,” said Laura Kaiser, Chair of the Board.
  • “As a Board Member myself, I’m excited to see how both Richard and Brad’s contributions and industry expertise continue to strengthen our organization.”
    With these appointments and Curtis' retirement, the Board of Directors consists of five Board Members, a Vice Chair and a Chair of the Board.

Florida Cancer Specialists & Research Institute Leaders Serve on Faculty for Value-Based Cancer Care Summit

Retrieved on: 
Wednesday, October 19, 2022

Fort Myers, Fla., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Fort Myers, Fla., October 19, 2022 Senior leaders of Florida Cancer Specialists & Research Institute (FCS) will serve on the faculty for the Association for Value-Based Cancer Care 2022 Summit & Educational Program being held in New York, NY on Oct. 19-21.

Key Points: 
  • Fort Myers, Fla., Oct. 19, 2022 (GLOBE NEWSWIRE) -- Fort Myers, Fla., October 19, 2022 Senior leaders of Florida Cancer Specialists & Research Institute (FCS) will serve on the faculty for the Association for Value-Based Cancer Care 2022 Summit & Educational Program being held in New York, NY on Oct. 19-21.
  • Florida Cancer Specialists & Research Institute has been a recognized leader in value-based oncology care efforts through is achievements in the Oncology Care Model (OCM) and through innovative partnerships with commercial payors.
  • FCS CEO Nathan H. Walcker said, The AVBCC Summit serves as a catalyst for shaping the future of cancer care.
  • About Florida Cancer Specialists & Research Institute, LLC: (FLCancer.com)
    Recognized by the American Society of Clinical Oncology (ASCO) with a national Clinical Trials Participation Award, Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any private oncology practice in Florida.

Global EV Charging Management Software Platform Market to Reach $25.92 Billion by 2031 - Exclusive DeepTech M-A-PTM Analysis by BIS Research

Retrieved on: 
Friday, September 23, 2022

FREMONT, Calif., Sept. 23, 2022 /PRNewswire/ -- BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled EV Charging Management Software Platform Market – A Global and Regional Analysis. 

Key Points: 
  • The EV charging management software platform is critical to business success because it addresses EV charging operators' requirements for operational excellence and EV driver satisfaction.
  • FREMONT, Calif., Sept. 23, 2022 /PRNewswire/ -- BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled EV Charging Management Software Platform Market A Global and Regional Analysis.
  • The EV charging management software platform allows EV charging operators and e-mobility service providers to manage all aspects of EV charging to maximize charger uptime and provide drivers with an exceptional EV charging experience.
  • This exclusive report on the global EV charging management software platform market will help in the following ways:
    Want to learn more about electric vehicles market trends?

Global EV Charging Management Software Platform Market to Reach $25.92 Billion by 2031 - Exclusive DeepTech M-A-PTM Analysis by BIS Research

Retrieved on: 
Friday, September 23, 2022

FREMONT, Calif., Sept. 23, 2022 /PRNewswire/ -- BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled EV Charging Management Software Platform Market – A Global and Regional Analysis. 

Key Points: 
  • The EV charging management software platform is critical to business success because it addresses EV charging operators' requirements for operational excellence and EV driver satisfaction.
  • FREMONT, Calif., Sept. 23, 2022 /PRNewswire/ -- BIS Research, the global leader in providing market intelligence on deep technologies, has released its latest study titled EV Charging Management Software Platform Market A Global and Regional Analysis.
  • The EV charging management software platform allows EV charging operators and e-mobility service providers to manage all aspects of EV charging to maximize charger uptime and provide drivers with an exceptional EV charging experience.
  • This exclusive report on the global EV charging management software platform market will help in the following ways:
    Want to learn more about electric vehicles market trends?